Interdent, Inc. – Trademark Portfolio
Entity Type: 03
Interdent, Inc. has 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include INTERDENT and CONTRAST P.M.. The portfolio includes 2 registered trademarks. Filings span 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 35 (Advertising & Business). This trademark owner is based in Inglewood, CA.
9920 La Cienega Blvd.
Inglewood, CA 90301
Showing of trademarks Trademarks
Trademark Classifications
Interdent, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Interdent, Inc. have?
Interdent, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 4 cancelled.
What trademark classes does Interdent, Inc. file in?
Interdent, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Interdent, Inc.'s most well-known trademarks?
Interdent, Inc.'s registered trademark portfolio includes well-known marks such as INTERDENT and CONTRAST P.M.. These are among 2 currently registered trademarks in the portfolio.
What is Interdent, Inc.'s trademark registration success rate?
Interdent, Inc. has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.